Insulin Glargine (Abasaglar®)

Assessment Status Rapid Review Complete
HTA ID -
Drug Insulin Glargine
Brand Abasaglar®
Indication For the treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
Assessment Process
Rapid review commissioned 04/09/2015
Rapid review completed 12/10/2015
Rapid review outcome Full Pharmacoeconomic Assessment Not Recommended